Searchable abstracts of presentations at key conferences in endocrinology

ea0051s4.3 | Diabetes Track 1: Symposium 4 | BSPED2017

Diabetes and technology. Current state of the art and future prospects

Acerini Carlo L

Advances in diabetes technology, particularly the introduction of continuous subcutaneous insulin infusion (CSII) pumps and of subcutaneous glucose sensing devices, have transformed the Type 1 diabetes (T1D) management landscape over the last 20 years. These devices have become more commonplace in our clinical practice, yet the evidence base that they have contributed to the modest improvements in glycaemic control in children and young people with T1D over these last two deca...

ea0027p9 | (1) | BSPED2011

A survey of patient/carer opinions and preferences on choice of GH injection device

Fisher Benjamin G , Gorman Samantha , Reyes Karis , Sparrow Susan , Acerini Carlo L

Introduction: Approximately 3200 children and young people in the UK receive GH therapy. Currently 12 different GH injection devices are available, with NHS guidance (NICE-TA188) recommending that patients/carers should have a choice of product. Whilst there is evidence that offering such choice may improve treatment adherence, little is known about its importance to patients/carers, nor whether device preferences should be reviewed after a period of treatment.<p class="ab...

ea0045p12 | Diabetes | BSPED2016

Identifying the barriers to effective diabetes ‘transitional care’. A qualitative study of patient satisfaction and experiences of transition

Wilson Kate , Ashford Jennifer , Olsen Paula , Slegtenhorst Sonja , Williams Rachel , Acerini Carlo L

Disparities in the quality of care for patients with type 1 diabetes (T1D) undergoing transition from children’s to adult services are well recognised. Poor planning and ill-defined care pathways promote patient disengagement with many becoming ‘lost’ to specialist follow-up for years. This study sought to obtain the views of young people’s experiences of transition to identify perceived barriers to an effective and rewarding transition experience. A qualit...

ea0066oc4.9 | Oral Communications 4 | BSPED2019

Health status of children aged 8–18 years with 21-hydroxylase deficiency in the United Kingdom: results of a multi-centre cohort study

Bacila Irina-Alexandra , Mahdi Sundus , Acerini Carlo L , Krone Ruth , Patel Leena , Alvi Sabah , Randell Tabitha , Gevers Evelien , Dattani Mehul , Cheetham Timothy , Kyriakou Andreas , Ryan Fiona , Crowne Elizabeth , Davies Justin H , Das Urmi , Ahmed S Faisal , Krone Nils

Introduction: There is limited knowledge on the impact of congenital adrenal hyperplasia (CAH) on the health and well-being of children and young persons (CYP). We aimed to establish the health status of CYP with CAH across the United Kingdom.Methods: We conducted a national multi-centre prospective study recruiting 107 patients aged 8–18 with 21-hydroxylase deficiency from 14 centres and 83 matched controls. Demographic, clinical, metabolic data, a...

ea0058oc4.6 | Oral Communications 4 | BSPED2018

Implementation of a novel non-invasive test for monitoring control in individuals with congenital adrenal hyperplasia

Bacila Irina , Acerini Carlo L , Krone Ruth E , Patel Leena , Alvi Sabah , Randel Tabitha , Gevers Evelin F , Dattani Mehul , Cheetham Timothy , Ryan Fiona , Crowne Elizabeth , Davies Justin , Faisal Ahmed , Kyriakou Andreas , Adaway Jo , Schiffer Lina , Keevil Brian , Krone Nils

Introduction: Monitoring of hormonal control represents a key part in the management of congenital adrenal hyperplasia (CAH). It remains suboptimal and relies on frequent blood tests, which are traumatising in children and young persons (CYP). Recent evidence suggests a crucial role of adrenal-derived 11-oxygenatedC19 androgens in the pathogenesis of CAH. Therefore, we aimed to establish a non-invasive test for monitoring of adrenal-specific androgens in CAH.<p class="abst...